Inhibition of angiogenic initiation and disruption of newly established human vascular networks by juice from Morinda citrifolia (noni)

Angiogenesis

Volumn 6, Issue 2, 2003, Pages 143-149

  Hornick, Conrad A ^a,b   Myers, Amy ^a   Sadowska Krowicka, Halina ^b   Anthony, Catherine T ^b   Woltering, Eugene A ^b,c,d  

^a Neuroscience Center at Louisiana State Health Sciences Center   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Apoptosis; Breast cancer; Endothelial cells; Noni

Indexed keywords

ANGIOGENESIS INHIBITOR; MORINDA CITRIFOLIA EXTRACT;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; BREAST TUMOR; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FIBRIN CLOT; FRUIT JUICE; GROWTH RATE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

ANGIOGENESIS INHIBITORS; BREAST NEOPLASMS; FEMALE; HUMANS; MORINDA; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PLACENTA; PLANT PREPARATIONS; PREGNANCY; TIME FACTORS;

MORINDA CITRIFOLIA;

EID: 0842268485     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:AGEN.0000011800.04507.4b     Document Type: Article

References (20)

1. Folkman J. Tumor angiogenesis: Theraputic implications. N Engl J Med 1971; 285: 1182-6.
2. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86(3): 353-64.
3. Clauss M, Sunderkotter C, Sveinbjornsson B et al. A permissive role for tumor necrosis factor in vascular endothelial growth factor-induced vascular permeability. Blood 2001; 97(5): 1321-9.
4. Gasparini G. The rationale and future potential of angiogenesis inhibitors in neoplasia. Drugs 1999; 58: 17-38.
5. Li WW. Tumor Angiogenesis: Molecular pathology, theraputic targeting, and imaging. Acta Radiol 2000; 7: 800-11.
6. Rosen L. Antiangiogenic strategies and agents in clinical trials. Oncologist 2000; 5(Suppl 1): 20-7.
7. Denekamp J. Vascular endothelium as the vulnerable element in tumors. Acta Radiol Oncol 1994; 23: 217-25.
8. Rosen LS. Angiogenesis inhibition in solid tumors. Cancer J 2001; 7(Suppl 3): S120-S8.
9. Hill S, Lonergan S, Denekamp J, Chaplin D. Vinca alkaloids: Anti-vascular effects in a murine tumor. Eur J Cancer 1993; 29: 1320-4.
10. Baguley B, Holdway K, Thomsen L et al. Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine. Evidence for a vascular mechanism. Eur J Cancer 1991; 27: 482-7.
11. Bibby M, Double J, Loadman P, Duke C. Reduction of tumor blood flow by flavone acetic acid: A possible mechanism of its anti-tumor action. J Natl Cancer Inst 1989; 81: 216-20.
12. Chaplin D, Pettit G, Hill S. Anti-vascular approaches to solid tumor therapy: Evaluation of combrestatin A4 phosphate. Anticancer Res 1999; 19: 189-96.
13. Abbot IA, Shimazu C. The geographical origin of the plants most commonly used for medicine by Hawaiians. J Ethnopharm 1985; 14: 213-22.
14. Krauss B. Plants in Hawaiian Culture. Honolulu, Hawaii: University of Hawaii Press 1993.
15. Hirazumi A. An immunomodulatory polysaccharide rich substance from the fruit juice of Morinda citrifolia (noni) with antitumor activity. Phytother Res 1999; 13: 380-7.
16. Hiramatsu T, Imoto M, Koyano T, Umezawa K. Induction of normal phenotypes in ras-transformed cells by damnacanthal from Morinda citrifolia. Cancer Lett 1993; 73: 161-6.
17. Drexler HC, Risau W, Konerding MA. Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells. FASEB J 2000; 14(1): 65-77.
18. r integrins. Science 1995; 270: 1500-2.
19. Cebo C, Vergoten G, Zanetta JP. Lectin activities of cytokines: Functions and putative carbohydrate-recognition domains. Biochim Biophys Acta 2002; 1572(2-3): 422-34.
20. Brooks PC, Montgomery AM et al. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994; 79(7): 1157-64.